Digest Network Come funziona
Network
/
Società
Fo
Non verificato

Foundation Medicine

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaOncologiaSalute

34 comunicati stampa

Guarda tutti i comunicati
23/10/2026
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Salute
Scienza
Oncologia
Eventi
Industria
Foundation Medicine’s FoundationOne®MRD Named a 2026 Top Innovation Winner by The Scientist
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
22/10/2026
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
21/10/2026
Scienza
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
Eventi
Industria
Foundation Medicine and Joint Collaborators to Present 12 Abstracts at the ESMO Congress 2026
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
16/07/2026
Multimedialità
Industria
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Foundation Medicine Drives Awareness on the Importance of Quality and Accuracy in Cancer Biomarker Testing
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
02/06/2026
Oncologia
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Industria
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for Itovebi™ (inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
01/06/2026
Mercato del lavoro
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Foundation Medicine and SWOG Clinical Trials Partnerships Announce Strategic Collaboration to Advance Biomarker-Driven Research and Clinical Trials
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
01/06/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Oncologia
US FDA Approves FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for TALZENNA® (talazoparib) in Combination with XTANDI® (enzalutamide) to Identify Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
29/05/2026
Oncologia
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Foundation Medicine Launches FoundationOne®MRD, First-of-Its-Kind Molecular Residual Disease Test to Combine Structural Variants and Digital PCR
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
28/05/2026
Biotecnologia
Tecnica
Salute
Sanità
Farmaceutica
Oncologia
Scienza
Software
Industria
Foundation Medicine to Launch Advanced Digital Solutions to Support Faster Cancer Treatment Decision Making
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0
22/05/2026
Eventi
Fiere
Scienza
Tecnica
Biotecnologia
Software
Farmaceutica
Salute
Oncologia
Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
Fonte
Foundation Medicine
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0